The policy includes a mid- and long-term roadmap for the new European research reactors. CEA (France), SCK•CEN (Belgium) and NRG (the Netherlands) allocated the following main functions for their new reactors:
- Reactor Jules Horowitz (Cadarache, France): a high performance materials testing reactor, already under construction;
- MYRRHA (Mol, Belgium): a flexible fast spectrum irradiation research facility; and
- Pallas (Petten, the Netherlands): a research reactor as the main European producer for medical isotopes.
- Opportunities for materials and fuel testing to support reactor safety, plant life management, optimization and innovation for current and future nuclear power reactors;
- Development of a flexible fast spectrum irradiation facility in order to put Europe in a leading position in the worldwide search for sustainable nuclear energy for tomorrow; and
- Radioisotope production for nuclear medicine, a major commitment to public health.
No comments:
Post a Comment